Northern Trust Fails to Get Proprietary Fund Suit Dismissed

A judge has rejected the defendants’ arguments that the same reasoning applied by two circuit courts in other cases should be applied to their case.

A federal judge has refused to dismiss a lawsuit against fiduciaries of the Northern Trust Company Thrift-Incentive Plan that alleges that because the defendants failed to remove underperforming funds from the plan or negotiate lower, reasonable fees, participants’ account balances have suffered.

The defendants moved to dismiss the complaint for failure to state a claim, arguing that the plaintiffs’ allegations are insufficient to lead to a finding that they violated their fiduciary duties. Judge Charles Ronald Norgle of the U.S. District Court for the Northern District of Illinois has denied the motion.

Never miss a story — sign up for PLANSPONSOR newsletters to keep up on the latest retirement plan benefits news.

Norgle noted in his opinion that the plaintiffs allege that the defendants violated their duty of loyalty by selecting and retaining plan investment options that generated unreasonable management fees for Northern Trust and by paying unreasonable recordkeeping fees. Specifically, the plaintiffs take issue with the defendants’ decision to retain the 11 Northern Trust Focus Funds, a target-date fund suite, despite being able to offer allegedly better-performing TDFs at the same or lesser cost.

According to the court opinion, since 2013, the Focus Funds have been the only target-date retirement investing options in the plan, and they were the default investment option for plan participants. Norgle noted that according to the complaint, even before their selection for the plan in 2013, the Focus Funds had underperformed relative to benchmark indices and comparable TDFs for three years.

The plaintiffs also allege that the defendants failed to conduct an appropriately competitive bidding process to negotiate low prices and imprudently selected and retained the higher-cost shares of investment options, when the “only difference between the shares classes is the amount of fees.”

Norgle pointed out that in their motion to dismiss, the defendants largely relied on a 2020 decision in Divane v. Northwestern University, in which the 7th U.S. Circuit Court of Appeals emphasized that “any participant could avoid . . . excessive recordkeeping fees and underperformance . . . simply by choosing from hundreds of other options.” However, he added, in a unanimous opinion, the Supreme Court vacated and remanded that decision in the case now known as Hughes v. Northwestern University. The high court held that the 7th Circuit’s reliance and “exclusive focus on investor choice” was flawed reasoning.

The defendants also cited wording in the 7th Circuit’s opinion in Divane to emphasize that the Employee Retirement Income Security Act does not “mandate what kind of benefits employers must provide” in an employee benefits plan. Norgle agreed that ERISA does not require that a plan offer TDFs, for example, but he pointed out that the plaintiffs are not arguing that it does. “They assert that a failure of adequate fiduciary process can be reasonably inferred from the totality of their allegations,” he noted. Norgle agreed with the plaintiffs’ assertion.

According to the court opinion, in a supplement to their motion to dismiss, the defendants compared their case to Smith v. CommonSpirit Health, in which the 6th U.S. Circuit Court of Appeals opined that “merely pointing to another investment that has performed better in a five-year snapshot of the lifespan of a fund that is supposed to grow for fifty years does not suffice to plausibly plead an imprudent decision.” Norgle noted that in contrast to the CommonSpirit case, the plaintiffs in the Northern Trust case “plead consistent, chronic underperformance for a decade.” In addition, he said that the CommonSpirit plaintiffs compared actively managed funds to passively managed funds, which the court described as “comparing apples and oranges,” while the plaintiffs in the Northern Trust case compare the Focus Funds to similar TDFs. “The court is not persuaded that this case is comparable to Smith, and the motion is denied,” Norgle wrote in his opinion.

Milliman Partners for Health Care Data Transparency

Milliman and Turquoise Health seek to automate health care price data to reduce administrative and contracting burdens for individuals, employers and health care providers.

Milliman, an actuarial and consulting firm, has partnered with Turquoise Health to increase health care price data transparency for market participants.

Tejas Inamdar, head of strategic partnerships at Turquoise Health, says that through the partnership, health care market participants will be able to access additional critical pricing data with which to make important care decisions.

Get more!  Sign up for PLANSPONSOR newsletters.

“Access to data will be table stakes for market participants wanting to engage in health care negotiations,” he says. “The next phase of price transparency will be to draw actionable information. This partnership combines capabilities and enables more health care organizations to leverage this wealth of new information by combining negotiated rates with proprietary data on utilization, relativities, reference pricing and groupers.”

Milliman’s Grouper software is used to analyze and benchmark use and costs using the Health Cost Guidelines. The tool sorts medical and pharmacy claims data into hospital, surgical, medical and other benefits service categories using Health Cost Guidelines definitions, according to Seattle-based Milliman.  

Beginning July 1, most group health plans and issuers of group or individual health insurance are required to post pricing information for covered items and services, following a 2019 executive order from President Donald Trump. Greater price data transparency can reduce time needed by employers for price discovery, assist employers with health benefit contract negotiations and help employees with health care costs, according to the release.

“Instead of spending precious time and resources just trying to wrangle the data, Turquoise and Milliman enable businesses to act strategically, making decisions based on data down to the market, cohort, and code level,” the partnership release states. “Price transparency data illuminates opportunities for improvement, arming healthcare stakeholders with the quantitative data they need to conduct granular analysis, generate insightful comparisons, and scrutinize competitor networks.”

The Transparency in Coverage Final Rule, issued by the Centers for Medicare and Medicaid Services, took effect January 1, 2021.The pricing data that exists for the industry and individuals is useful if it can be unlocked, said Mike Gaal, principal and consulting actuary with Milliman, in a release.

“The data set that has become available this year is the largest collection of healthcare data ever published,” he said. “The wealth of information has the potential to transform the industry—but gathering and deciphering all that data requires a unique blend of healthcare expertise and scalable technology.”

This payer data ranges from in-network negotiated rates to out-of-network allowed amounts for hospitals, surgery center labs imaging centers professional fees and durable equipment, according to the release.  

“The availability of this data will affect every stakeholder involved in the healthcare interaction,” Inamdar added in the release.

For the partnership, Milliman will use its proprietary data enrichment tools and analytics to turn this machine-readable data into insights that can be used by businesses.

Turquoise Health is a health care technology startup that was launched in 2020. The company uses machine learning to assist with making health care price transparency data accessible, according to a spokesperson. Turquoise uses data engineering and machine learning to automate processing thousands of payer and provider files containing millions of records in multiple formats.

«